Skin infections in Europe: a retrospective study of incidence, patient characteristics and practice patterns-Reference-Cited by-同舟云学术

Skin infections in Europe: a retrospective study of incidence, patient characteristics and practice patterns

Published:2022-09 Issue:3 Volume:60 Page:106637
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Grossi Antonio Paolo,Ruggieri Alessandro,Vecchio Alessandra Del,Comandini Alessandro,Corio Luciana,Calisti Fabrizio,Loreto Giorgio Di,Almirante Benito^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital;Pollack;J Emerg Med,2015

2. New insights into classification, epidemiology and microbiology of SSTIs, including diabetic foot infections;Esposito;Infez Med,2018

3. Guidance document: Acute bacterial skin and skin structure infections: developing drugs for treatment,2013

4. Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs;Falcone;Intern Emerg Med,2016

5. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study;Garau;Clin Microbiol Infect,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Nonvenereal Infections in Spanish Dermatology Clinics: Results of the DIADERM Study;Actas Dermo-Sifiliográficas;2023-06

2. Enfermedades infecciosas no venéreas atendidas en consultas de Dermatología en España: resultados del estudio DIADERM;Actas Dermo-Sifiliográficas;2023-06

3. Antibiotic Management of Uncomplicated Skin and Soft Tissue Infections in the Real World;Microorganisms;2023-05-24

4. A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens;ACS Infectious Diseases;2023-05-03

5. Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals;JAC-Antimicrobial Resistance;2023-03-02